Back to Search
Start Over
Intracranial Pressure During the Development of Renovascular Hypertension
- Source :
- Web of Science, Repositório Institucional da UNESP, Universidade Estadual Paulista (UNESP), instacron:UNESP
- Publication Year :
- 2021
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2021.
-
Abstract
- Made available in DSpace on 2021-06-25T15:01:55Z (GMT). No. of bitstreams: 0 Previous issue date: 2021-04-01 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) Pro-Reitoria de Pesquisa -Sao Paulo State University The mechanisms by which changes in intracranial pressure (ICP) occur during hypertension are unclear. The experimental 2K1C (2-kidney, 1-clip) hypertension is a model characterized by sympathetic and renin-angiotensin system overactivation in which ICP still needs investigation. In the present study, we analyzed ICP alterations during the development of 2K1C hypertension using invasive and noninvasive ICP recording methods. We also tested the importance of AT1R (angiotensin II type 1 receptor) activation for the ICP changes and investigated the integrity of the blood-brain barrier within central cardioregulatory nuclei in 2K1C hypertensive rats. 2K1C hypertension was induced in 6-week-old male rats (150 g). In the fourth week of 2K1C hypertension induction, when mean arterial pressure reached 162 +/- 2 mm Hg, ICP significantly increased, ICP pulse waveforms changed, increasing the ratio between the two peaks (P2/P1 ratio) of the ICP waveform. In the third week of 2K1C hypertension induction, blood-brain barrier disruption was detected within the hypothalamic paraventricular nucleus, rostral ventrolateral medulla, and nucleus tractus solitarius. In the sixth week, intravenous losartan (AT1R antagonist) or the vasodilator hydralazine acutely reduced arterial pressure to normotensive levels. Losartan, but not hydralazine, partially reduced the increase of ICP and P2/P1 ratio in hypertensive rats. These results show significant changes in ICP in 2K1C hypertensive rats and suggest that AT1R activation may contribute to elevated ICP during hypertension-an effect possibly intensified by the blood-brain barrier disruption in important central cardioregulatory nuclei in renovascular hypertensive animals. Sao Paulo State Univ, Sch Dent Araraquara, Dept Physiol & Pathol, Rua Humaita 1680, BR-14801 Araraquara, SP, Brazil Auburn Univ, Dept Anat Physiol & Pharmacol, Coll Vet Med, Auburn, AL 36849 USA Auburn Univ, Ctr Neurosci Res Initiat, Auburn, AL 36849 USA Sao Paulo State Univ, Sch Dent Araraquara, Dept Physiol & Pathol, Rua Humaita 1680, BR-14801 Araraquara, SP, Brazil CAPES: CAPES PROEX-0487 FAPESP: 2015/23467-7
- Subjects :
- medicine.medical_specialty
hypertension
Intracranial Pressure
losartan
intracranial pressure
angiotensin II
030204 cardiovascular system & hematology
Losartan
Receptor, Angiotensin, Type 1
Renovascular hypertension
03 medical and health sciences
0302 clinical medicine
Internal medicine
Solitary Nucleus
Internal Medicine
medicine
Animals
Intracranial pressure
Ventral Thalamic Nuclei
integumentary system
business.industry
musculoskeletal, neural, and ocular physiology
medicine.disease
Angiotensin II
Rats
nervous system diseases
Disease Models, Animal
Hypertension, Renovascular
Blood pressure
Blood-Brain Barrier
Cardiology
arterial pressure
Intracranial Hypertension
business
Angiotensin II Type 1 Receptor Blockers
030217 neurology & neurosurgery
Paraventricular Hypothalamic Nucleus
medicine.drug
Subjects
Details
- ISSN :
- 15244563 and 0194911X
- Volume :
- 77
- Database :
- OpenAIRE
- Journal :
- Hypertension
- Accession number :
- edsair.doi.dedup.....270c3c282f7607ac8f297cd6087ff888
- Full Text :
- https://doi.org/10.1161/hypertensionaha.120.16217